knowledge -WSS

knowledge

author：knowledge 2025-09-03 03:40:32 - browse：8

Has PhRMA lost its fangs? Are 11th-hour changes ominous for clinical trials? And what’s next in pain medicine?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. The pharmaceutical industry, in court and in Congress, is working to water down legislation that will let Medicare negotiate certain drug prices. STAT Washington correspondent Rachel Cohrs joins us to explain the industry’s struggle to make headway — and how it factors into the 2024 election. We also discuss the latest news in the life sciences, including a twist in the future of Alnylam Pharmaceuticals, competition to Vertex Pharmaceuticals’ pain drug, and Gilead Sciences’ latest acquisition.

For more on what we cover, here’s all of Rachel’s coverage; here’s more on Vertex’s competition; here’s the news on Gilead; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： People with mental disorders often marry others with same

WSS

Mass General Brigham physicians react to latest merger step

Acelyrin, a rare IPO success, stumbles in its first big test

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

Scientists uncover potential path to treating deadly childhood tumor

Medicare Advantage 2025 payments will dip, Biden administration says

Food makers tried to stack nutrition panel with preferred experts

entertainment

knowledge

leisure time

What does generative AI mean for health care? We asked experts

Oral obesity drug from Viking Therapeutics hits key early target

State Dept. review finds Biden bears some blame for Afghanistan failures

PEPFAR is under serious threat — and so is global health

New air purifier tech could be key to improving indoor air quality

How to make the FDA’s new prescription one

Hollywood unions extend contract negotiations for actors

People with mental disorders often marry others with same

What does generative AI mean for health care? We asked experts

FDA approves updated Covid vaccines

knowledge

UnitedHealth, in a surprise, takes aim at Steward’s physician group

First Opinion on colorectal cancer screening: letter and response

Long Covid needs a new name — and a new frame

How to make the FDA’s new prescription one

Study: Black kids more likely to die after surgery than white kids

Will the IRA bring competition to the biologics market?

knowledge

Wikipedia

explore

Wikipedia